Bristol-Myers Squibb to Take Part in UBS Global Healthcare Conference
May 16 2017 - 6:59AM
Business Wire
Bristol-Myers Squibb Company (NYSE: BMY) will take part in the
UBS Global Healthcare Conference on Monday, May 22, 2017, in New
York. Murdo Gordon, executive vice president, head of Commercial,
will answer questions about the company at 10 a.m. EDT.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. An archived
edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, and YouTube.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170516005260/en/
Bristol-Myers Squibb CompanyMedia:Ken Dominski,
609-252-5251ken.dominski@bms.comorInvestors:Tim Power
609-252-7509timothy.power@bms.comorBill Szablewski,
609-252-5894william.szablewski@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024